Table 1.
Scale | Derivation dataset | Location | Recruitment type | Enrolment dates | Stroke type | Exclusion criteria of note |
---|---|---|---|---|---|---|
ASTRAL | Acute Stroke Registry and Analysis of Lausanne | Switzerland | Single-center | Jan 2003 to Jul 2010 | Ischemic | Pre-stroke mRS > 2 |
DRAGON | Bespoke cohort | Finland | Single-center | 1995 to Sep 2010 | Ischemic | Basilar artery occlusions |
FSV | Stroke Outcome Study | Canada | Single-center | 2001 to 2002 | Ischemic, hemorrhagic | |
iSCORE | Registry of the Canadian Stroke Network | Canada | Multi-center | Jul 2003 to Jun 2008 | Ischemic | |
PLAN | Registry of the Canadian Stroke Network | Canada | Multi-center | Jul 2003 to Mar 2008 | Ischemic | Patients receiving IV-tPA |
SNARL | Endovascular registry | Unclear | Multi-center | Sep 2009 to Jul 2011 | Ischemic | |
SOAR | Anglia Stroke and Heart Clinical Network Database | United Kingdom | Multi-center | 1997 to 2010 | Ischemic, hemorrhagic | |
SPI | Carotid ultrasound register | United States | Single-center | Jan 1984 to Feb 1987 | Ischemic | Artificial heart valves, previous cerebrovascular event |
S-TPI | NINDS 1 & 2, ATLANTIS A & B, ECASS 2 cohorts | International | Multi-center | Jan 1991 to Jul 1998* | Ischemic | Multiple, related to primary randomized control trials; minor strokes |
THRIVE | MERCI, Multi MERCI cohorts | International | Multi-center | May 2001 to Dec 2003; Jan 2004 to Jul 2006 | Ischemic | Multiple, related to primary single-arm trials. |
IV-tPA, intravenous tissue plasminogen activator; mRS, modified Rankin Scale.
Combined recruitment period for all trials.